American Society of Clinical Oncology. (2016, August). Ovarian, Fallopian Tube, and Peritoneal Cancer. Retrieved from: http://www.cancer.net/cancer-types/ovarian-cancer/view-all.
Black D, Barakat RR. Fallopian tube cancer. Raghavan D, Blanke CD, Honson DH, et al (eds.). (2012). Textbook of Uncommon Cancer. (4th Edition). Wiley Blackwell. 38: 531 - 539.
Cannistra SA, Gershenson DM, Recht A. Ovarian cancer, fallopian tube carcinoma, and peritoneal carcinoma. DeVita VT Jr, Lawrence TS, Rosenberg SA. (2015). Cancer: Principles and Practice of Oncology. (10th Edition). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. 76: 1075-1099.
Koskela-Niska V, Pukkala, Lyytinen H, Ylikorkala O, Dyba T. Postmenopausal hormone therapy-also use of estradiol plus levonorgestrel-intrauterine system is associated with an increased risk of primary fallopian tube carcinoma. (2015, October 15). International Journal of Cancer. 137(8):1947-52. Retrieved from: https://www.ncbi.nlm.nih.gov/pubmed/?term=25846583.
National Cancer Institute. (2016, August 12). Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer Treatment for Health Professionals (PDQ®). Retrieved from: https://www.cancer.gov/types/ovarian/hp/ovarian-epithelial-treatment-pdq.
Vicus D, Finch A, Rosen B, et al. Risk factors for carcinoma of the fallopian tube in women with and without a germline BRCA mutation. (2009, December 2). Gynecologic Oncology. Academic Press. 118 (2010) 155–159.×